Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 282Gynecologic 110Breast 64Head & Neck 31CNS 30Genitourinary 27Gastrointestinal 21Other solid neoplasm 10Tumor-Agnostic 8Lymphoid 6Sarcoma 5Dermatologic 4Endocrine 2Other 1Classical hematology 1

Conditions

Carcinoma, Ovarian Epithelial 1Anemia 1

Interventions

Epoetin Alfa 27Darbepoetin alfa 13Cytarabine 9Dalteparin 8Rivaroxaban 7Daunorubicin 7apixaban 6Etoposide 6Methotrexate 5Idarubicin 5Heparin, Low-Molecular-Weight 5Cyclophosphamide 5emicizumab 4Tinzaparin 4Thioguanine 4Mitoxantrone 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Enoxaparin 4pegfilgrastim 3hetrombopag 3epoetin beta 3Saline Solution 3Radiotherapy 3Hydrocortisone 3Erythropoietin 3Dexamethasone 3Aspirin 3Asparaginase 3telapristone acetate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carboplatin × Classical hematology × Clear all
NCT00189371 2005-09-19

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

AGO Study Group

Phase 3 Terminated
300 enrolled
Classical hematologyGynecologic

Carcinoma, Ovarian Epithelial, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡